Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update

Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update

Abstract Autosomal Dominant Polycystic Kidney Disease (ADPKD) affects up to 70 000 people in the UK and the most common inherited cause of end-stage kidney disease (ESKD). It is generally a late-onset multisystem disorder characterised by bilateral kidney cysts, liver cysts and an increased risk of...

Full description

Saved in:
Bibliographic Details
Main Authors: Matt Gittus, Helen Haley, Tess Harris, Sarah Borrows, Neal Padmanabhan, Danny Gale, Roslyn Simms, Terri Williams, Aaron Acquaye, Alisa Wong, Melanie Chan, Eduardo Lee, Albert CM Ong
Format: Article
Language:English
Published: BMC 2025-02-01
Series:BMC Nephrology
Subjects:
Autosomal Dominant polycystic kidney disease
ADPKD
Tolvaptan
Online Access:https://doi.org/10.1186/s12882-025-03960-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12882-025-03960-4

Similar Items